EQL Pharma AB (publ) (STO:EQL)
25.40
+0.85 (3.46%)
At close: Jun 15, 2026
EQL Pharma AB Employees
EQL Pharma AB had 60 employees as of March 31, 2026. The number of employees increased by 39 or 185.71% compared to the previous year.
Employees
60
Change
39
Growth
185.71%
Revenue / Employee
7.21M SEK
Profits / Employee
208.97K SEK
Market Cap
750.05M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 60 | 39 | 185.71% |
| Dec 31, 2025 | 55 | 27 | 96.43% |
| Sep 30, 2025 | 54 | 34 | 170.00% |
| Jun 30, 2025 | 20 | -2 | -9.09% |
| Mar 31, 2025 | 21 | 0 | - |
| Dec 31, 2024 | 28 | 9 | 47.37% |
| Sep 30, 2024 | 20 | 2 | 11.11% |
| Jun 30, 2024 | 22 | 4 | 22.22% |
| Mar 31, 2024 | 21 | 3 | 16.67% |
| Dec 31, 2023 | 19 | 6 | 46.15% |
| Sep 30, 2023 | 18 | 4 | 28.57% |
| Jun 30, 2023 | 18 | 4 | 28.57% |
| Mar 31, 2023 | 18 | 5 | 38.46% |
| Dec 31, 2022 | 13 | 2 | 18.18% |
| Sep 30, 2022 | 14 | 3 | 27.27% |
| Jun 30, 2022 | 14 | 3 | 27.27% |
| Mar 31, 2022 | 13 | 3 | 30.00% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BioGaia AB | 242 |
| Orexo AB | 65 |
| Enzymatica AB | 21 |
| Cinclus Pharma Holding AB | 21 |
| Nanexa AB | 16 |
| Cereno Scientific AB | 10 |
| Newbury Pharmaceuticals AB | 7 |
| Moberg Pharma AB | 5 |
EQL Pharma AB News
- 5 weeks ago - EQL Pharma AB Transcript: Q4 25/26 - Transcripts
- 5 weeks ago - EQL Pharma AB Quarterly report: Q4 2026 - Filings
- 4 months ago - EQL Pharma AB Earnings Call Transcript: Q3 2026 - Transcripts
- 4 months ago - EQL Pharma AB Quarterly report: Q3 2026 - Filings
- 7 months ago - EQL Pharma AB Transcript: Q2 25/26 - Transcripts
- 7 months ago - EQL Pharma AB Quarterly report: Q2 2026 - Filings
- 11 months ago - EQL Pharma AB Transcript: Q1 25/26 - Transcripts
- 11 months ago - EQL Pharma AB Quarterly report: Q1 2026 - Filings